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The ductular reaction is proposed to initiate liver fibrosis but the
causal mechanisms are not known. Monocyte chemotaxis pro-
tein-1 (MCP-1) is expressed in both hepatocytes and cholan-
giocytes in pediatric cholestatic liver diseases and induces
chemotaxis of hepatic stellate cells (1). This study aimed to char-
acterise the ductular reaction in pediatric cholestasis and to
assess its role in hepatic MCP-1 expression and thus in the
development of hepatic fibrosis. Methods: Liver from patients
with cystic fibrosis associated liver disease (CFLD) (n=65), bil-
iary atresia (n=3) neonatal hepatitis (n=5) and control subjects
(n=5) were immunohistochemically stained for cytokeratin-7
(CK-7) to assess the ductular reaction and for MCP-1. The results
were correlated with the degree of hepatic fibrosis (Scheuer).
Dual immunofluorescence was used to determine if CK-7 and
MCP-1 co-localised to cells of the ductular reaction. Hepatic
progenitor cell lines (BMOL and PIL-2) were treated with the bile
acid taurocholic acid (TCA) and MCP-1 mRNA expression
determined by real-time RT-PCR. Migration assays were per-
formed using hepatic stellate cells and conditioned-media from
the progenitor cells ±TCA. Migration inhibition assays were
performed using an anti-MCP-1 antibody. Results: The ductular
reaction was increased in pediatric cholestatic liver disease
and consisted of expanded reactive bile ducts, hepatic pro-
genitor cells and intermediate hepatocytes. This was most pro-
nounced in patients with acute liver diseases such as bilary
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atresia (P=0.05) and neonatal hepatitis (P=0.04). In CFLD,
where it was possible to stratify specimens according to the
degree of fibrosis, the ductular reaction increased with increas-
ing fibrosis (Spearman r=0.59, P<0.0001). Dual immunofluo-
rescence confirmed that cells of the ductular reaction express
both CK-7 and MCP-1. Progenitor cells treated with 150µM
TCA showed increased MCP-1 mRNA expression. Significant
chemotaxis of hepatic stellate cells was induced by conditioned-
media from BMOL (1.7 fold, P=0.01) and PIL-2 (1.9 fold,
P=0.0084) progenitor cells treated with TCA. This migration
was inhibited by an anti-MCP-1 antibody. Conclusion: The duc-
tular reaction correlates with increasing stage of hepatic fibro-
sis in pediatric cholestasis. MCP-1 is expressed by hepatic
progenitor cells. In vitro, progenitor cells exposed to the bile
acid TCA secrete MCP-1, which is chemoattractive to stellate
cells. Thus, MCP-1 derived from progenitor cells of the ductular
reaction may recruit stellate cells and initiate fibrosis in pedi-
atric cholestatic liver diseases. (1) Ramm et all Hepatology
2009:49:533-544.
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